Barrett's esophagus specialist clinic: What difference can it make?

Diseases of the Esophagus

Volumn 19, Issue 2, 2006, Pages 84-87

  Anagnostopoulos, G K ^a   Pick, B ^a   Cunliffe, R ^a   Fortun, P ^a   Kaye, P ^a   Ragunath, K ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Barrett's esophagus; Specialist clinic; Surveillance

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOSCOPY; ESOPHAGUS BIOPSY; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE FACILITY; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAGNIFICATION RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; OUTPATIENT; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST; SYMPTOM; TREATMENT PLANNING; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; ESOPHAGOSCOPY; FEMALE; GASTROENTEROLOGY; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PRACTICE GUIDELINES; QUESTIONNAIRES; SPECIALTIES, MEDICAL;

EID: 33645155806     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00545.x     Document Type: Article

References (15)

1. Fitzgerald R C. Genetics and prevention of oesophageal adenocarcinoma. Recent Results Cancer Res 2005; 166: 35-46.
2. Paulson T G, Reid B J. Focus on Barrett's esophagus and esophageal adenocarcinoma. Cancer Cell 2004; 6: 11-16.
3. Canto M I. Barrett's esophagus. Gastrointest Endosc Clin N Am 2005; 15: 83-92.
4. Craanen M E, Blok P, Meijer G A, Meuwissen S G. Surveillance in Barrett's oesophagus: A critical reappraisal. Scand J Gastroenterol Suppl 2002; 236: 4-8.
5. Spechler S J, Barr H. Review article: Screening and surveillance of Barrett's oesophagus: What is a cost-effective framework? Aliment Pharmacol Ther 2004; 19: 49 -53.
6. Sonnenberg A, Soni A, Sampliner R E. Medical decision analysis of endoscopic surveillance of Barrett's oesophagus to prevent oesophageal adenocarcinoma. Aliment Pharmacol Ther 2002; 16: 41-50.
7. Fitzgerald R C. Review article: Barrett's oesophagus and associated adenocarcinoma -a UK perspective. Aliment Pharmacol Ther 2004; 20: 45-49.
8. Mandal A, Playford R J, Wicks A C. Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK. Aliment Pharmacol Ther 2003; 17: 1319-1324.
9. Smith A M, Maxwell-Armstrong C A, Welch N T, Scholefield J H. Surveillance for Barrett's oesophagus in the UK. Br J Surg 1999; 86: 276-280.
10. Sampliner R E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 2002; 97: 1888-1895.
11. Weston A P, Badr A S, Hassanein R S. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 1999; 94: 3413-3419.
12. Hillman L C, Chiragakis L, Clarke A C, Kaushik S P, Kaye G L. Barrett's esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma. J Gastroenterol Hepatol 2003; 18: 526-533.
13. Tschanz E R. Do 40% of patients resected for Barrett's oesophagus with high grade dysplasia have unsuspected adenocarcinoma? Arch Pathol Lab Med 2005; 129: 177-180.
14. Guelrud M, Herrera I, Essenfeld H, Castro J. Enhanced magnification endoscopy: A new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 2001; 53: 559-565.
15. Lambert R, Rey J F, Sankaranarayanan R. Magnification and chromoscopy with the acetic acid test. Endoscopy 2003; 35: 37-45.